304 related articles for article (PubMed ID: 21371192)
1. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience.
Holmström M; Tran HT; Holme PA
Haemophilia; 2012 Jul; 18(4):544-9. PubMed ID: 22348384
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
Tran HT; Sørensen B; Rea CJ; Bjørnsen S; Ueland T; Pripp AH; Tjønnfjord GE; Holme PA
Haemophilia; 2014 May; 20(3):369-75. PubMed ID: 24251535
[TBL] [Abstract][Full Text] [Related]
5. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
7. An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
Rea CJ; Foley JH; Bevan DH; Sørensen B
Ann Hematol; 2014 Apr; 93(4):683-92. PubMed ID: 24193375
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
[TBL] [Abstract][Full Text] [Related]
9. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
10. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.
Hvas AM; Sørensen HT; Norengaard L; Christiansen K; Ingerslev J; Sørensen B
J Thromb Haemost; 2007 Dec; 5(12):2408-14. PubMed ID: 18034766
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.
Tang M; Wierup P; Rea CJ; Ingerslev J; Hjortdal VE; Sørensen B
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):295-302. PubMed ID: 27607599
[TBL] [Abstract][Full Text] [Related]
13. Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.
Antovic A; Mikovic D; Elezovic I; Zabczyk M; Hutenby K; Antovic JP
Thromb Haemost; 2014 Apr; 111(4):656-61. PubMed ID: 24258360
[TBL] [Abstract][Full Text] [Related]
14. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.
Janbain M; Enjolras N; Bordet JC; Bolbos R; Brevet M; Leissinger C; Dargaud Y
J Thromb Haemost; 2020 Mar; 18(3):584-592. PubMed ID: 31782901
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tranexamic Acid on Coagulation and Fibrin Clot Properties in Children Undergoing Craniofacial Surgery.
Fenger-Eriksen C; Lindholm AD; Krogh L; Hell T; Berger M; Hermann M; Fries D; Juul N; Rasmussen M; Hvas AM
Thromb Haemost; 2020 Mar; 120(3):392-399. PubMed ID: 32016928
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic.
Salaj P; Penka M; Smejkal P; Geierova V; Ovesná P; Brabec P; Cetkovsky P; Kubes R; Mesterton J; Lindgren P
Thromb Res; 2012 May; 129(5):e233-7. PubMed ID: 22386136
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
Beckman JD; Holle LA; Wolberg AS
J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
